After a median follow-up of @ months , median progression-free survival ( according to independent radiologic review ) was @ months in the R-CHOP group versus @ months in the VR-CAP group ( hazard ratio favoring the VR-CAP group , @ ; P < @ ) , a relative improvement of @ % .